Wordt geladen...
Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal
In the field of rare diseases (RDs), the evidence standard is often lower than that required by health technology assessment (HTA) and payer authorities. In this commentary, we propose that appropriate economic evaluation for rare disease treatments should be initially informed by cost-of-illness (C...
Bewaard in:
| Gepubliceerd in: | Int J Environ Res Public Health |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7908548/ https://ncbi.nlm.nih.gov/pubmed/33530652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph18031101 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|